Breast Cancer
Conference Coverage
Fasting during breast cancer chemo improves quality of life
Short-term fasting around the time of chemotherapy is a promising supportive therapy during breast cancer chemotherapy that may enhance quality of...
Conference Coverage
Adjuvant abemaciclib-ET combo shows long-term benefit in high-risk early breast cancer
Invasive disease–free and distant recurrence–free survival were better with the CDK4/6 inhibitor plus endocrine therapy than endocrine therapy...
Latest News
FDA proposes ban on hair straightener ingredients
The proposal specifies that formaldehyde would be banned, as well as other chemicals that release formaldehyde, such as methylene glycol.
Commentary
Male patients with breast cancer: Special considerations and gender-specific concerns
Even the materials that we have are gender specific. I think those things all together can certainly contribute to a man feeling like a fish out...
Latest News
What the first authorized DNA cancer risk test can and can’t tell you
The test can identify genetic variants that increase an individual’s risk of certain cancers and help identify potential cancer-related hereditary...
News
This is how you get patients back for follow-up cancer testing
“What concerns me is that despite the various interventions implemented to encourage and support patients to return for follow-up testing, over 60...
Conference Coverage
Adopting high-dose radiation vs. conventional after mastectomy could be ‘game changer’
The use of the higher-dose approach, known as hypofractionation, “resulted in fewer treatment breaks and less financial toxicity.”
Latest News
USPSTF should reconsider recommendation to lower mammogram age: Experts
The benefit is arguably small, while the harms appear quite significant.
Latest News
Older women who get mammograms risk overdiagnosis
The proportion of older women who continue to receive screening mammograms and may experience breast cancer overdiagnosis is “considerable” and “...
Latest News
Adhering to endocrine therapy is hard. What can be done?
Given the array of potential obstacles to endocrine therapy adherence, improving long-term use may be equally complex.